Please read and agree to the terms and conditions of this site.
@slashgear.com 4 years ago
FDA issues strong warning to avoid all THC and ‘street’ vapes
@slashgear.com 4 years ago
High blood pressure drug recall expands again over cancer risk
@slashgear.com 4 years ago
Another popular heartburn drug gets FDA cancer warning
@xconomy.com 4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@slashgear.com 4 years ago
Popular migraine drug recalled over potentially serious bacteria risk
@slashgear.com 4 years ago
Superbug tuberculosis treatment gets FDA approval as cases skyrocket
@slashgear.com 4 years ago
The FDA just fast-tracked this new blood cancer treatment
@slashgear.com 4 years ago
FDA warns thousands of wireless insulin pumps can be hacked
@slashgear.com 4 years ago
Blood pressure drug recall expands again: What you need to know
@slashgear.com 4 years ago
FDA reveals change that’ll help bring cheaper generic drugs to the US
@slashgear.com 4 years ago
Another blood pressure drug tests positive for cancer-causing compound
@slashgear.com 4 years ago
FDA approves $2.1m gene therapy for infants with rare genetic disease
@xconomy.com 5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com 5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com 5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com 5 years ago
Losing “Scalps”? Despite Pharma Fear, A Split on Trump Rx-Price Plans
@xconomy.com 5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com 5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com 5 years ago
Delivery Robots in Big D, Rodriguez Leaves the Station, & More TX Tech
@xconomy.com 5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com 5 years ago
Alnylam Won’t Seek Quick FDA Nod For Second RNAi Drug
@xconomy.com 5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com 5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com 5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug
@xconomy.com 5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com 5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
@xconomy.com 5 years ago
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
@xconomy.com 5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets
@engadget.com 5 years ago
FDA approves its first marijuana-derived drug
@techcrunch.com 5 years ago
With CBD, marijuana-based medicine gets its first greenlight from the FDA
@xconomy.com 5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
@xconomy.com 5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@xconomy.com 6 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
@xconomy.com 6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed
@cryptocoinsnews.com 7 years ago
Blockchain Tech to be Researched by US Food and Drug Administration
@techcrunch.com 7 years ago
FDA issues new security guidelines so that your pacemaker won’t get hacked
@venturebeat.com 8 years ago
This Microsoft Kinect-powered physical therapy app is FDA-approved
@venturebeat.com 9 years ago
FDA releases guidance on regulation of ‘wellness’ med devices and accessories